Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CD4 Lymphocyte Count And NotDavid Coetzee

List of bibliographic references

Number of relevant bibliographic references: 85.
Ident.Authors (with country if any)Title
000005 Mary-Ann Davies [Afrique du Sud] ; Priscilla Tsondai [Afrique du Sud] ; Nicki Tiffin [Afrique du Sud] ; Brian Eley [Afrique du Sud] ; Helena Rabie [Afrique du Sud] ; Jonathan Euvrard [Afrique du Sud] ; Catherine Orrell [Afrique du Sud] ; Hans Prozesky [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Dolphina Cogill [Afrique du Sud] ; Andreas D. Haas [Suisse] ; Annette H. Sohn [Thaïlande] ; Andrew Boulle [Afrique du Sud]Where do HIV-infected adolescents go after transfer? - Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform.
000045 Carolyn M. Audet [États-Unis] ; Sizzy Ngobeni [Afrique du Sud] ; Ryan G. Wagner [Afrique du Sud]Traditional healer treatment of HIV persists in the era of ART: a mixed methods study from rural South Africa.
000056 Johan Herman Cronje [Afrique du Sud] ; Margaret Williams [Afrique du Sud] ; Liana Steenkamp [Afrique du Sud] ; Danie Venter [Afrique du Sud] ; Diane Elkonin [Afrique du Sud]The quality of life of HIV-infected South African university students: Experiences with the WHOQOL-HIV-Bref.
000149 Maria Paximadis [Afrique du Sud] ; Refilwe N. Ngqobe [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Neil A. Martinson [Afrique du Sud] ; Caroline T. Tiemessen [Afrique du Sud]RICH2 is implicated in viraemic control of HIV-1 in black South African individuals.
000176 Rachel Arnesen [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Sheela V. Shenoi [États-Unis]Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa.
000261 Jennifer Onwumeh ; Charles I. Okwundu ; Tamara Kredo [Afrique du Sud]Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
000274 Mhairi Maskew [Afrique du Sud] ; Jacob Bor [Afrique du Sud] ; Cheryl Hendrickson [Afrique du Sud] ; William Macleod [Afrique du Sud] ; Till B Rnighausen [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; Ian Sanne [Afrique du Sud] ; Sergio Carmona [Afrique du Sud] ; Wendy Stevens [Afrique du Sud] ; Matthew P. Fox [Afrique du Sud]Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.
000335 Sharon A. Riddler [États-Unis] ; Marla Husnik [États-Unis] ; Gita Ramjee [Afrique du Sud] ; Anamika Premrajh [Afrique du Sud] ; Bomkazi Onini Tutshana [Afrique du Sud] ; Arendevi Pather [Afrique du Sud] ; Samantha Siva [Afrique du Sud] ; Nitesha Jeenarain [Afrique du Sud] ; Gonasagrie Nair [Afrique du Sud] ; Pearl Selepe [Afrique du Sud] ; Samuel Kabwigu [Ouganda] ; Thesla Palanee-Phillips [Afrique du Sud] ; Ravindre Panchia [Afrique du Sud] ; Felix Mhlanga [Zimbabwe] ; Lisa Levy [États-Unis] ; Edward Livant [États-Unis] ; Karen Patterson [États-Unis] ; Vanessa Elharrar [États-Unis] ; Jennifer Balkus [États-Unis]HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
000345 Radha Rajasingham [États-Unis] ; Rachel M. Smith [États-Unis] ; Benjamin J. Park [États-Unis] ; Joseph N. Jarvis [Botswana] ; Nelesh P. Govender [Afrique du Sud] ; Tom M. Chiller [États-Unis] ; David W. Denning [Royaume-Uni] ; Angela Loyse [Royaume-Uni] ; David R. Boulware [États-Unis]Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
000366 Akshay N. Gupte [États-Unis] ; Michelle L. Wong [Afrique du Sud] ; Reginah Msandiwa [Afrique du Sud] ; Grace L. Barnes [États-Unis] ; Jonathan Golub [États-Unis] ; Richard E. Chaisson [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Neil A. Martinson [Afrique du Sud]Factors associated with pulmonary impairment in HIV-infected South African adults.
000378 Naseem Cassim [Afrique du Sud] ; Kathryn Schnippel [Afrique du Sud] ; Lindi Marie Coetzee [Afrique du Sud] ; Deborah Kim Glencross [Afrique du Sud]Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
000388 Soter Ameh [Afrique du Sud, Nigeria] ; Kerstin Klipstein-Grobusch [Afrique du Sud, Pays-Bas] ; Eustasius Musenge [Afrique du Sud] ; Kathleen Kahn [Afrique du Sud, Ghana, Suède] ; Stephen Tollman [Afrique du Sud, Ghana, Suède] ; Francesc Xavier G Mez-Olivé [Afrique du Sud, Ghana]Effectiveness of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted Time-Series Analysis
000390 Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark]Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
000425 Allison L. Agwu [États-Unis] ; Meredith G. Warshaw [États-Unis] ; Elizabeth J. Mcfarland [États-Unis] ; George K. Siberry [États-Unis] ; Ann J. Melvin [États-Unis] ; Andrew A. Wiznia [États-Unis] ; Lee Fairlie [Afrique du Sud] ; Sandra Boyd [États-Unis] ; Paul Harding [États-Unis] ; Hans M L. Spiegel [États-Unis] ; Elaine J. Abrams [États-Unis] ; Vincent J. Carey [États-Unis]Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
000441 Cristin Q. Fritz [États-Unis] ; Meridith Blevins [États-Unis] ; Mary Lou Lindegren [États-Unis] ; Kara Wools-Kaloutsian [États-Unis] ; Beverly S. Musick [États-Unis] ; Morna Cornell [Afrique du Sud] ; Kelly Goodwin [Suisse] ; Dianne Addison [États-Unis] ; Jean Claude Dusingize [Rwanda] ; Eugène Messou [Côte d'Ivoire] ; Armel Poda [Burkina Faso] ; Stephany N. Duda [États-Unis] ; Catherine C. Mcgowan [États-Unis] ; Matthew G. Law [Australie] ; Richard D. Moore [États-Unis] ; Aimee Freeman [États-Unis] ; Denis Nash [États-Unis] ; C William Wester [États-Unis]Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.
000456 Reneé De Waal [Afrique du Sud] ; Karen Cohen [Afrique du Sud] ; Matthew P. Fox [États-Unis] ; Kathryn Stinson [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Andrew Boulle [Afrique du Sud] ; Ehimario U. Igumbor [Afrique du Sud] ; Mary-Ann Davies [Afrique du Sud]Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.
000458 Eric Nagaonlé Somé [Norvège] ; Ingunn M S. Engebretsen [Norvège] ; Nicolas Nagot [France] ; Nicolas Y. Meda [Burkina Faso] ; Roselyne Vallo [France] ; Chipepo Kankasa [Zambie] ; James K. Tumwine [Ouganda] ; Mandisa Singata [Afrique du Sud] ; Justus G. Hofmeyr [Afrique du Sud] ; Philippe Van De Perre [France] ; Thorkild Tyllesk R [Norvège]Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial).
000481 Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie]Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
000489 Philip J. Palumbo [États-Unis] ; Ethan A. Wilson [États-Unis] ; Estelle Piwowar-Manning [États-Unis] ; Marybeth Mccauley [États-Unis] ; Theresa Gamble [États-Unis] ; Newton Kumwenda [Malawi] ; Joseph Makhema [Botswana] ; Nagalingeswaran Kumarasamy [Inde] ; Suwat Chariyalertsak [Thaïlande] ; James G. Hakim [Zimbabwe] ; Mina C. Hosseinipour [États-Unis] ; Marineide G. Melo [Brésil] ; Sheela V. Godbole [Inde] ; Jose H. Pilotto [Brésil] ; Beatriz Grinsztejn [Brésil] ; Ravindre Panchia [Afrique du Sud] ; Ying Q. Chen [États-Unis] ; Myron S. Cohen [États-Unis] ; Susan H. Eshleman [États-Unis] ; Jessica M. Fogel [États-Unis]Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.
000497 Lindi Marie Coetzee [Afrique du Sud] ; Naseem Cassim ; Deborah Kim GlencrossAnalysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support.
000616 Sylvie Boyer [France] ; Collins Iwuji [Afrique du Sud] ; Andréa Gosset [France] ; Camelia Protopopescu [France] ; Nonhlanhla Okesola [Afrique du Sud] ; Mélanie Plazy [France] ; Bruno Spire [France] ; Joanna Orne-Gliemann [France] ; Nuala Mcgrath [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; François Dabis [France] ; Joseph Larmarange [Afrique du Sud]Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
000629 Ingrid V. Bassett [États-Unis] ; Sharon M. Coleman [États-Unis] ; Janet Giddy [Afrique du Sud] ; Laura M. Bogart [États-Unis] ; Christine E. Chaisson [États-Unis] ; Douglas Ross [Afrique du Sud] ; Moses J. E. Flash [États-Unis] ; Tessa Govender [Afrique du Sud] ; Rochelle P. Walensky [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Elena Losina [États-Unis]Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa
000687 Aysel Gueler [Afrique du Sud] ; Franziska Schoeni-Affolter ; André Moser ; Barbara Bertisch ; Heiner C. Bucher ; Alexandra Calmy ; Matthias Cavassini ; Bruno Ledergerber ; Gilles Wandeler ; Matthias EggerNeighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland.
000754 Barbara M. Heinze [Afrique du Sud] ; Bart M. Vinck [Belgique] ; Louis M. Hofmeyr [Afrique du Sud] ; De Wet Swanepoel [Australie]Vestibular involvement in adults with HIV/AIDS.
000819 Naadira Vanker [Afrique du Sud] ; Hayley IppLarge unstained cells: a potentially valuable parameter in the assessment of immune activation levels in HIV infection.
000823 Geoffrey Fatti [Afrique du Sud] ; Najma Shaikh ; Brian Eley ; Ashraf GrimwoodImproved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
000828 Andrew Tomita [Afrique du Sud] ; Nigel Garrett ; Lise Werner ; Jonathan K. Burns ; Lindiwe Mpanza ; Koleka Mlisana ; Francois Van Loggerenberg ; Salim S. Abdool KarimHealth-related quality of life dynamics of HIV-positive South African women up to ART initiation: evidence from the CAPRISA 002 acute infection cohort study.
000830 R. Kader [Afrique du Sud] ; S. Seedat ; R. Govender ; J R Koch ; C D ParryHazardous and harmful use of alcohol and/or other drugs and health status among South African patients attending HIV clinics.
000874 Samantha Black [Afrique du Sud] ; Rose Zulliger ; Rebecca Marcus ; Daniella Mark ; Landon Myer ; Linda-Gail BekkerAcceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa.
000895 Gilles Wandeler [Afrique du Sud] ; Thomas Gsponer ; Lloyd Mulenga ; Daniela Garone ; Robin Wood ; Mhairi Maskew ; Hans Prozesky ; Christopher Hoffmann ; Jochen Ehmer ; Diana Dickinson ; Mary-Ann Davies ; Matthias Egger ; Olivia KeiserZidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
000898 Michael Schomaker [Afrique du Sud] ; Matthias Egger ; James Ndirangu ; Sam Phiri ; Harry Moultrie ; Karl Technau ; Vivian Cox ; Janet Giddy ; Cleophas Chimbetete ; Robin Wood ; Thomas Gsponer ; Carolyn Bolton Moore ; Helena Rabie ; Brian Eley ; Lulu Muhe ; Martina Penazzato ; Shaffiq Essajee ; Olivia Keiser ; Mary-Ann DaviesWhen to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
000908 Mhairi Maskew [Afrique du Sud] ; Matthew P. Fox ; Gilles Van Cutsem ; Kathryn Chu ; Patrick Macphail ; Andrew Boulle ; Matthias Egger ; For Iedea Southern AfricaTreatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
000912 Naadira Vanker [Afrique du Sud] ; Hayley IppThe use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.
000932 Anna Dow [États-Unis] ; Dumbani Kayira [Malawi] ; Michael G. Hudgens [États-Unis] ; Annelies Van Rie [États-Unis] ; Caroline C. King [États-Unis] ; Sascha Ellington [États-Unis] ; Nelecy Chome [Malawi] ; Athena Kourtis [États-Unis] ; Abigail Norris Turner [États-Unis] ; Zebrone Kacheche [Malawi] ; Denise J. Jamieson [États-Unis] ; Charles Chasela [Afrique du Sud] ; Charles Van Der Horst [États-Unis]The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
000942 Ankur Gupta-Wright [Afrique du Sud] ; Robin Wood ; Linda-Gail Bekker ; Stephen D. LawnTemporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
000987 K N Otwombe [Afrique du Sud] ; E. Variava ; C B Holmes ; R E Chaisson ; N. MartinsonPredictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa.
000991 Naseem Cassim [Afrique du Sud] ; Lindi Coetzee ; Bahule Motlonye ; Nobantu Mpele ; Deborah K. GlencrossPiloting a national laboratory electronic programme status reporting system.
000A26 Landon Myer [Afrique du Sud] ; Monika Kamkuemah ; Richard Kaplan ; Linda-Gail BekkerLow prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
000A30 Leigh F. Johnson [Afrique du Sud] ; Joel Mossong [Afrique du Sud] ; Rob E. Dorrington [Afrique du Sud] ; Michael Schomaker [Afrique du Sud] ; Christopher J. Hoffmann [Afrique du Sud, États-Unis] ; Olivia Keiser [Suisse] ; Matthew P. Fox [États-Unis, Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Hans Prozesky [Afrique du Sud] ; Janet Giddy [Afrique du Sud] ; Daniela Belen Garone [Afrique du Sud] ; Morna Cornell [Afrique du Sud] ; Matthias Egger [Suisse] ; Andrew Boulle [Afrique du Sud]Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
000A37 V M S. Kalumba [Afrique du Sud] ; J. Moodley ; T D NaidooIs the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case-control study.
000A39 Cathy Nisha John [Afrique du Sud] ; Lawrence Xavier Stephen ; Charlene Wilma Joyce AfricaIs human immunodeficiency virus (HIV) stage an independent risk factor for altering the periodontal status of HIV-positive patients? A South African study.
000A46 Kate Clouse [Afrique du Sud] ; Audrey Pettifor ; Mhairi Maskew ; Jean Bassett ; Annelies Van Rie ; Cynthia Gay ; Frieda Behets ; Ian Sanne ; Matthew P. FoxInitiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
000A53 S. Danaviah [Afrique du Sud] ; J A Sacks ; K P S. Kumar ; L M Taylor ; D A Fallows ; T. Naicker ; T. Ndung'U ; S. Govender ; G. KaplanImmunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients.
000A54 Michael Schomaker [Afrique du Sud] ; Matthias Egger ; Mhairi Maskew ; Daniela Garone ; Hans Prozesky ; Christopher J. Hoffmann ; Andrew Boulle ; Lukas FennerImmune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
000A63 Heidi Van Rooyen [Afrique du Sud] ; Ruanne V. Barnabas ; Jared M. Baeten ; Zipho Phakathi ; Philip Joseph ; Meighan Krows ; Ting Hong ; Pamela M. Murnane ; James Hughes ; Connie CelumHigh HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
000A66 Jeffrey W. Eaton [Royaume-Uni] ; Nicolas A. Menzies [États-Unis] ; John Stover [États-Unis] ; Valentina Cambiano [Royaume-Uni] ; Leonid Chindelevitch [États-Unis] ; Anne Cori [Royaume-Uni] ; Jan A C. Hontelez [Pays-Bas] ; Salal Humair [États-Unis] ; Cliff C. Kerr [Australie] ; Daniel J. Klein [États-Unis] ; Sharmistha Mishra [Canada] ; Kate M. Mitchell [Royaume-Uni] ; Brooke E. Nichols [Pays-Bas] ; Peter Vickerman [Royaume-Uni] ; Roel Bakker [Pays-Bas] ; Till B Rnighausen [États-Unis] ; Anna Bershteyn [États-Unis] ; David E. Bloom [États-Unis] ; Marie-Claude Boily [Royaume-Uni] ; Stewart T. Chang [États-Unis] ; Ted Cohen [États-Unis] ; Peter J. Dodd [Royaume-Uni] ; Christophe Fraser [Royaume-Uni] ; Chaitra Gopalappa [États-Unis] ; Jens Lundgren [Danemark] ; Natasha K. Martin [Royaume-Uni] ; Evelinn Mikkelsen [Pays-Bas] ; Elisa Mountain [Royaume-Uni] ; Quang D. Pham [Australie] ; Michael Pickles [Royaume-Uni] ; Andrew Phillips [Royaume-Uni] ; Lucy Platt [Royaume-Uni] ; Carel Pretorius [États-Unis] ; Holly J. Prudden [Royaume-Uni] ; Joshua A. Salomon [États-Unis] ; David A M C. Van De Vijver [Pays-Bas] ; Sake J. De Vlas [Pays-Bas] ; Bradley G. Wagner [États-Unis] ; Richard G. White [Royaume-Uni] ; David P. Wilson [Australie] ; Lei Zhang [Australie] ; John Blandford [États-Unis] ; Gesine Meyer-Rath [Afrique du Sud] ; Michelle Remme [Royaume-Uni] ; Paul Revill [Royaume-Uni] ; Nalinee Sangrujee [États-Unis] ; Fern Terris-Prestholt [Royaume-Uni] ; Meg Doherty [Suisse] ; Nathan Shaffer [Suisse] ; Philippa J. Easterbrook [Suisse] ; Gottfried Hirnschall [Suisse] ; Timothy B. Hallett [Royaume-Uni]Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
000A70 Karl Peltzer [Afrique du Sud, Thaïlande]HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: A longitudinal study
000A71 Charles Feldman [Afrique du Sud] ; Ronald AndersonHIV-associated bacterial pneumonia.
000A86 Sophia Pathai [Royaume-Uni, Afrique du Sud] ; Clare Gilbert [Royaume-Uni] ; Helen A. Weiss [Royaume-Uni] ; Colin Cook [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni]Frailty in HIV-infected adults in South Africa
000A93 Shabir A. Madhi [Afrique du Sud] ; Sylvia Dittmer ; Locadiah Kuwanda ; Marietjie Venter ; Haseena Cassim ; Erica Lazarus ; Teena Thomas ; Afaaf Liberty ; Florette Treurnich ; Clare L. Cutland ; Adriana Weinberg ; Avy ViolariEfficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
000B22 Peter Bock [Afrique du Sud] ; Geoffrey Fatti ; Ashraf GrimwoodComparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
000B58 Sophia Pathai [Royaume-Uni, Afrique du Sud] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Clare E. Gilbert [Royaume-Uni] ; Dagmara Mcguinness [Royaume-Uni] ; Liane Mcglynn [Royaume-Uni] ; Helen A. Weiss [Royaume-Uni] ; Jennifer Port [Royaume-Uni] ; Theresa Christ [Royaume-Uni] ; Karen Barclay [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Paul G. Shiels [Royaume-Uni]Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study
000C57 Jacob Bor [États-Unis, Afrique du Sud] ; Frank Tanser [Afrique du Sud] ; Marie-Louise Newell [Afrique du Sud, Royaume-Uni] ; Till B Rnighausen [États-Unis, Afrique du Sud]Nearly Full Employment Recovery Among South African HIV Patients On Antiretroviral Therapy: Evidence From A Large Population Cohort
000C72 Sheree R. Schwartz [Afrique du Sud] ; Shruti H. Mehta ; Taha E. Taha ; Helen V. Rees ; Francois Venter ; Vivian BlackHigh pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.
000D63 Karl Peltzer [Afrique du Sud] ; Shandir Ramlagan ; Mohamed Salim Khan ; Bernhard GaedeThe social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
000D78 Karl Peltzer [Afrique du Sud] ; Shandir RamlaganPerceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa.
000D88 Marianne W. Mureithi [Afrique du Sud] ; Kristen Cohen ; Ramona Moodley ; Danielle Poole ; Zenele Mncube ; Anne Kasmar ; D Branch Moody ; Philip J R. Goulder ; Bruce D. Walker ; Marcus Altfeld ; Thumbi Ndung'UImpairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.
000E58 D. Cristina Stefan [Afrique du Sud] ; David K. Stones [Afrique du Sud] ; Linda Wainwright [Afrique du Sud] ; Robert Newton [Royaume-Uni]Kaposi sarcoma in South African children
000E86 Anna Coutsoudis [Afrique du Sud] ; Kirsty England ; Nigel Rollins ; Hoosen Coovadia ; Marie-Louise Newell ; Ruth BlandWomen's morbidity and mortality in the first 2 years after delivery according to HIV status.
000E95 Stephanus Komati [Afrique du Sud] ; Pamela A. Shaw ; Nomso Stubbs ; Monkwe J. Mathibedi ; Lizette Malan ; Phumelele Sangweni ; Julia A. Metcalf ; Henry Masur ; Shaheen HassimTuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
000E96 Stephen D. Lawn [Afrique du Sud] ; Katharina Kranzer ; David J. Edwards ; Matthew Mcnally ; Linda-Gail Bekker ; Robin WoodTuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.
000E98 Salim S. Abdool Karim [Afrique du Sud] ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool KarimTiming of initiation of antiretroviral drugs during tuberculosis therapy.
000E99 Catherine F. Houlihan [Afrique du Sud] ; Portia C. Mutevedzi ; Richard J. Lessells ; Graham S. Cooke ; Frank C. Tanser ; Marie-Louise NewellThe tuberculosis challenge in a rural South African HIV programme.
000F12 Morna Cornell [Afrique du Sud] ; Anna Grimsrud ; Lara Fairall ; Matthew P. Fox ; Gilles Van Cutsem ; Janet Giddy ; Robin Wood ; Hans Prozesky ; Lerato Mohapi ; Claire Graber ; Matthias Egger ; Andrew Boulle ; Landon MyerTemporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.
000F29 John Hargrove [Afrique du Sud] ; Jean HumphreyShort communication: Simplified estimation of the long-term specificity of the BED assay to improve estimates of HIV incidence.
000F33 A. Samie [Afrique du Sud] ; L J Barrett ; P O Bessong ; J N Ramalivhana ; L G Mavhandu ; M. Njayou ; R L GuerrantSeroprevalence of Entamoeba histolytica in the context of HIV and AIDS: the case of Vhembe district, in South Africa's Limpopo province.
000F41 Christopher J. Hoffmann [Afrique du Sud] ; Katherine L. Fielding ; Salome Charalambous ; Craig Innes ; Richard E. Chaisson ; Alison D. Grant ; Gavin J. ChurchyardReducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
000F55 Lindi Roberts [Afrique du Sud] ; Jo-Ann S. Passmore ; Carolyn Williamson ; Francesca Little ; Lisa M. Bebell ; Koleka Mlisana ; Wendy A. Burgers ; Francois Van Loggerenberg ; Gerhard Walzl ; Joel F. Djoba Siawaya ; Quarraisha Abdool Karim ; Salim S Abdool KarimPlasma cytokine levels during acute HIV-1 infection predict HIV disease progression.
000F57 Edana Cassol [Afrique du Sud] ; Susan Malfeld ; Phetole Mahasha ; Schalk Van Der Merwe ; Sharon Cassol ; Chris Seebregts ; Massimo Alfano ; Guido Poli ; Theresa RossouwPersistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.
000F74 Caroline T. Tiemessen [Afrique du Sud] ; Sharon Shalekoff ; Stephen Meddows-Taylor ; Diana B. Schramm ; Maria A. Papathanasopoulos ; Glenda E. Gray ; Gayle G. Sherman ; Ashraf H. Coovadia ; Louise KuhnNatural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.
000F84 Bruce A. Larson [États-Unis] ; Alana Brennan [États-Unis] ; Lynne Mcnamara [Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Sydney Rosen [États-Unis] ; Ian Sanne [Afrique du Sud] ; Matthew P Fox [États-Unis]Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa
001003 Angela Loyse [Afrique du Sud] ; Helen Wainwright ; Joseph N. Jarvis ; Tihana Bicanic ; Kevin Rebe ; Graeme Meintjes ; Thomas S. HarrisonHistopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure.
001046 Shabir A. Madhi [Afrique du Sud] ; Peter Adrian ; Mark F. Cotton ; James A. Mcintyre ; Patrick Jean-Philippe ; Shawn Meadows ; Sharon Nachman ; Helena K Yhty ; Keith P. Klugman ; Avye ViolariEffect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.
001055 Kartik K. Venkatesh [États-Unis] ; Guy De Bruyn [Afrique du Sud] ; Mark N. Lurie [États-Unis] ; Lerato Mohapi [Afrique du Sud] ; Paul Pronyk [États-Unis] ; Mosa Moshabela [Afrique du Sud] ; Edmore Marinda [Afrique du Sud] ; Glenda E. Gray [Afrique du Sud] ; Elizabeth W. Triche [États-Unis] ; Neil A. Martinson [Afrique du Sud, États-Unis]Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics
001066 Dominique J. Pepper [Afrique du Sud] ; Suzaan Marais ; Robert J. Wilkinson ; Feriyl Bhaijee ; Gary Maartens ; Helen Mcilleron ; Virginia De Azevedo ; Helen Cox ; Cheryl Mcdermid ; Simiso Sokhela ; Janisha Patel ; Graeme MeintjesClinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.
001078 Valerie Asselman [Afrique du Sud] ; Friedrich Thienemann ; Dominique J. Pepper ; Andrew Boulle ; Robert J. Wilkinson ; Graeme Meintjes ; Suzaan MaraisCentral nervous system disorders after starting antiretroviral therapy in South Africa.
001085 Deven Patel [Afrique du Sud] ; Ruth Bland ; Hoosen Coovadia ; Nigel Rollins ; Anna Coutsoudis ; Marie-Louise NewellBreastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children.
001086 Colleen F. Hanrahan [États-Unis] ; Jonathan E. Golub [États-Unis] ; Lerato Mohapi [Afrique du Sud] ; Nkeko Tshabangu [Afrique du Sud] ; Tebogo Modisenyane [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Glenda E. Gray [Afrique du Sud] ; James A. Mcintyre [Afrique du Sud] ; Neil A. Martinson [États-Unis, Afrique du Sud]Body mass index and risk of tuberculosis and death
001094 Salome Charalambous [Afrique du Sud] ; Alison D. Grant ; Craig Innes ; Christopher J. Hoffmann ; Rob Dowdeswell ; Jan Pienaar ; Katherine L. Fielding ; Gavin J. ChurchyardAssociation of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
001102 Habtom H. Habte [Afrique du Sud] ; Corena De Beer ; Zoë E. Lotz ; Paul Roux ; Anwar S. MallAnti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
001108 Kavidha Reddy [Afrique du Sud] ; Cheryl A. Winkler ; Lise Werner ; Koleka Mlisana ; Salim S. Abdool Karim ; Thumbi Ndung'UAPOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
001827 G. Maartens [Afrique du Sud] ; R. Wood ; E. O'Keefe ; C. ByrneIndependent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences.
001889 M. Moodley [Afrique du Sud]Reduction in prevalence of invasive cervical cancer in KwaZulu-Natal, South Africa: impact of the human immunodeficiency virus epidemic.
001892 Kebede Deribe [Oman] ; Alemeshet Yami [Éthiopie] ; Amare Deribew [Éthiopie] ; Nebiyu Mesfin [Éthiopie] ; Robert Colebunders [Belgique] ; Jean Pierre Van Geertruyden [Belgique] ; Mirkuzie Woldie [Éthiopie] ; Todd Maja [Afrique du Sud]Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.
001898 Ingrid Eshun-Wilson [Afrique du Sud] ; Fiona Havers ; Jean B. Nachega ; Hans W. Prozesky ; Jantjie J. Taljaard ; Michele D. Zeier ; Mark Cotton ; Gary Simon ; Patrick SoentjensEvaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings.

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024